$3.71
2.16%
Downside
Day's Volatility :10.81%
Upside
8.85%
8.36%
Downside
52 Weeks Volatility :77.69%
Upside
75.66%
Period | Boundless Bio, Inc. | Index (Russel 2000) |
---|---|---|
3 Months | -67.87% | 0.0% |
6 Months | -73.75% | 0.0% |
1 Year | -73.75% | 0.0% |
3 Years | -73.75% | -20.2% |
Market Capitalization | 301.1M |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -33.13% |
Return On Equity TTM | -52.93% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -53.8M |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 1483.56%
Sell
Neutral
Buy
Boundless Bio, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Boundless Bio, Inc. | -6.5% | -73.75% | -73.75% | -73.75% | -90.57% |
![]() Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
![]() Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
![]() Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
![]() Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Boundless Bio, Inc. | NA | NA | NA | 0.0 | -0.53 | -0.33 | NA | NA |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
![]() Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
![]() Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
![]() Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Boundless Bio, Inc. | NA | $301.1M | -90.57% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
![]() Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Organization | Boundless Bio, Inc. |
Employees | 72 |
CEO | Dr. Jonathan E. Lim M.D. |
Industry | Health Technology |
A Spac I Acquisition Corp
$3.71
-0.8%
Keyarch Acquisition Corp
$3.71
-0.8%
Connexa Sports Technologies Inc
$3.71
-0.8%
Us Value Etf
$3.71
-0.8%
First Wave Biopharma Inc
$3.71
-0.8%
Global X Msci Next Emerging
$3.71
-0.8%
Fat Projects Acquisition Corp
$3.71
-0.8%
Capital Link Global Fintech
$3.71
-0.8%
Applied Uv Inc
$3.71
-0.8%